Study Design Considerations for Transbronchoscopic Thermal Ablation (TTA) Devices for the Treatment of Oligometastatic Disease in the Lung (OML) (Day 1)

The purpose of the workshop is to provide a forum for stakeholders, including clinicians and professional societies, patients, and manufacturers to share information that will assist FDA in developing appropriate regulatory review approaches to ensure the safety and effectiveness of this novel local therapy for the treatment of OML.